Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine

Journal of the American College of Cardiology

Volumn 68, Issue 22, 2016, Pages 2454-2464

  Kulandavelu, Shathiyah ^a   Karantalis, Vasileios ^a   Fritsch, Julia ^a   Hatzistergos, Konstantinos E ^a   Loescher, Viky Y ^a   McCall, Frederic ^a   Wang, Bo ^a   Bagno, Luiza ^a   Golpanian, Samuel ^a   Wolf, Ariel ^a   Grenet, Justin ^a   Williams, Adam ^a   Kupin, Aaron ^a   Rosenfeld, Aaron ^a   Mohsin, Sadia ^b   Sussman, Mark A ^b   Morales, Azorides ^a   Balkan, Wayne ^a   Hare, Joshua M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

heart failure; human cardiac progenitor cells; injection; pressure volume

Indexed keywords

PROTEIN KINASE PIM 1; STEM CELL FACTOR RECEPTOR; FUNGAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PIM1 PROTEIN, PICHIA PASTORIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PROTECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; PORCINE MODEL; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; YORKSHIRE PIG; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MYOCARDIAL INFARCTION; PIG; PROCEDURES;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; SWINE;

EID: 84999635843     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.09.925     Document Type: Article

References (40)

1. 1 Golpanian, S., Wolf, A., Hatzistergos, K.E., Hare, J.M., Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev 96 (2016), 1127–1168.
2. 2 Fischer, K.M., Cottage, C.T., Wu, W., et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 120 (2009), 2077–2087.
3. 3 Muraski, J.A., Rota, M., Misao, Y., et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 13 (2007), 1467–1475.
4. 4 Mohsin, S., Khan, M., Toko, H., et al. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol 60 (2012), 1278–1287.
5. 5 Fischer, K.M., Cottage, C.T., Konstandin, M.H., et al. Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling. J Mol Cell Cardiol 51 (2011), 554–558.
6. 6 Mohsin, S., Khan, M., Nguyen, J., et al. Rejuvenation of human cardiac progenitor cells with Pim-1 kinase. Circ Res 113 (2013), 1169–1179.
7. 7 McCall, F.C., Telukuntla, K.S., Karantalis, V., et al. Myocardial infarction and intramyocardial injection models in swine. Nat Protoc 7 (2012), 1479–1496.
8. 8 Williams, A.R., Hatzistergos, K.E., Addicott, B., et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127 (2013), 213–223.
9. 9 Karantalis, V., Suncion-Loescher, V.Y., Bagno, L., et al. Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol 66 (2015), 1990–1999.
10. 10 Ambale-Venkatesh, B., Lima, J.A., Cardiac MRI: a central prognostic tool in myocardial fibrosis. Nat Rev Cardiol 12 (2015), 18–29.
11. 11 Swindle, M.M., Makin, A., Herron, A.J., Clubb, F.J. Jr., Frazier, K.S., Swine as models in biomedical research and toxicology testing. Vet Pathol 49 (2012), 344–356.
12. 12 Nozawa, T., Cheng, C.P., Noda, T., Little, W.C., Effect of exercise on left ventricular mechanical efficiency in conscious dogs. Circulation 90 (1994), 3047–3054.
13. 13 Beltrami, A.P., Barlucchi, L., Torella, D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003), 763–776.
14. 14 Hatzistergos, K.E., Takeuchi, L.M., Saur, D., et al. cKit+ cardiac progenitors of neural crest origin. Proc Natl Acad Sci U S A 112 (2015), 13051–13056.
15. 15 Urbanek, K., Cesselli, D., Rota, M., et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A 103 (2006), 9226–9231.
16. 16 van Berlo, J.H., Kanisicak, O., Maillet, M., et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509 (2014), 337–341.
17. 17 Ellison, G.M., Vicinanza, C., Smith, A.J., et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154 (2013), 827–842.
18. 18 Leri, A., Kajstura, J., Anversa, P., Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res 109 (2011), 941–961.
19. 19 Bolli, R., Chugh, A.R., D'Amario, D., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378 (2011), 1847–1857.
20. 20 Makkar, R.R., Smith, R.R., Cheng, K., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379 (2012), 895–904.
21. 21 Yacoub, M.H., Terrovitis, J., CADUCEUS, SCIPIO, ALCADIA: cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving. Glob Cardiol Sci Pract 2013 (2013), 5–8.
22. 22 Karantalis, V., Balkan, W., Schulman, I.H., Hatzistergos, K.E., Hare, J.M., Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol 303 (2012), H256–H270.
23. 23 Telukuntla, K.S., Suncion, V.Y., Schulman, I.H., Hare, J.M., The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc, 2, 2013, e000338.
24. 24 Terrovitis, J.V., Smith, R.R., Marban, E., Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 106 (2010), 479–494.
25. 25 Keith, M.C., Tang, X.L., Tokita, Y., et al. Safety of intracoronary infusion of 20 million C-kit positive human cardiac stem cells in pigs. PloS One, 10, 2015, e0124227.
26. 26 Samse, K., Emathinger, J., Hariharan, N., et al. Functional effect of Pim1 depends upon intracellular localization in human cardiac progenitor cells. J Biol Chem 290 (2015), 13935–13947.
27. 27 Dai, Y., Xu, M., Wang, Y., Pasha, Z., Li, T., Ashraf, M., HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 42 (2007), 1036–1044.
28. 28 Mangi, A.A., Noiseux, N., Kong, D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003), 1195–1201.
29. 29 Gnecchi, M., He, H., Noiseux, N., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20 (2006), 661–669.
30. 30 Wang, Z., Bhattacharya, N., Weaver, M., et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci 2 (2001), 167–179.
31. 31 Cottage, C.T., Neidig, L., Sundararaman, B., et al. Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells. Stem Cells 30 (2012), 2512–2522.
32. 32 Borillo, G.A., Mason, M., Quijada, P., et al. Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ Res 106 (2010), 1265–1274.
33. 33 Shirogane, T., Fukada, T., Muller, J.M., Shima, D.T., Hibi, M., Hirano, T., Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 11 (1999), 709–719.
34. 34 Sussman, M.A., Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte. Expert Rev Cardiovasc Ther 7 (2009), 929–938.
35. 35 Hatzistergos, K.E., Quevedo, H., Oskouei, B.N., et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107 (2010), 913–922.
36. 36 Wendland, K., Thielke, M., Meisel, A., Mergenthaler, P., Intrinsic hypoxia sensitivity of the cytomegalovirus promoter. Cell Death Dis, 6, 2015, e1905.
37. 37 Walter, I., Fleischmann, M., Klein, D., et al. Rapid and sensitive detection of enhanced green fluorescent protein expression in paraffin sections by confocal laser scanning microscopy. Histochem J 32 (2000), 99–103.
38. 38 Sousounis, K., Baddour, J.A., Tsonis, P.A., Aging and regeneration in vertebrates. Curr Top Dev Biol 108 (2014), 217–246.
39. 39 Fan, M., Chen, W., Liu, W., et al. The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res 13 (2010), 429–438.
40. 40 Hare, J.M., Fishman, J.E., Gerstenblith, G., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308 (2012), 2369–2379.